Who founded Flare Therapeutics?

Flare Therapeutics was founded by Jim Audia, Jacob Stuckey.

Who are Flare Therapeutics's investors?

Flare Therapeutics's investors include NexTech Ventures, Pfizer Ventures, Third Rock Ventures, Nextech Invest, Pfizer Venture Investments, ShangBay Capital LLC, Agent Capital.

How much funding has Flare Therapeutics raised?

Flare Therapeutics has disclosed $85M raised across 1 of its 4 known rounds.

Flare Therapeutics

7 known investors

Find your way into Flare Therapeutics

132 people in our graph share verified history with the Flare Therapeutics team — schools, employers, funds. One of them is your warm intro.

Kevin Munnellyunlockedknows Jacob Stuckey · together at Third Rock Ventures (overlapped)

×10knows the team · via Third Rock Ventures

knows the team · via Constellation Pharma

Flare Therapeutics develops small molecule medicines targeting transcription factors using a chemistry and proteomics platform that enables ligand discovery directly from cells. The company has lead programs in prostate cancer and advanced urothelial cancer, and maintains a partnership with Roche.

AI & Machine Learning Biotech Deep Tech Healthtech

Founders & leadership

Jim AudiaExecutive Vice President, Drug Discovery and Early Development, and Founding Scientist

Jacob Stuckey inSenior Director, Biochemistry and Chemical Biology, and Founding ScientistJacob Stuckey is a chemical biologist and founding scientist at Flare Therapeutics, where he serves as Senior Director of Biochemistry and Chemical Biology and focuses on small molecule medicine development.

Investors · 7

NexTech Ventures✓ verifiedPrague

Pfizer Ventures✓ verified

Third Rock Ventures✓ verifiedBoston · $100K – $5M

Nextech InvestZurich · $648K – $3.2M

Pfizer Venture Investments$5M – $20M

ShangBay Capital LLCPalo Alto

Agent CapitalreportedWaltham

Funding

SEC filings, press & company announcements

$85M disclosed across 1 of 4 rounds · 2021–2026

Undisclosed amountSeries CJul 2026
Source ↗
$85MSeries CJun 2026 · 2 sources
Source ↗
Undisclosed amountSeries AMay 2021
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Flare Therapeutics Raised $85 Million to Drug Transcription Factors, Which Is Extremely Cambridgesiliconsnark.com · Jul 2026

Flare Therapeutics Raises $85M Series C Fundingallsci.com · Jul 2026

Flare Therapeutics Secures $85M in Insider-Led Series C Financing and Appoints Anna Protopapas as Chief Executive Officer - Flare Therapeutics | Flare Therapeuticsflaretx.com · Jun 2026

Flare Therapeutics Secures $85M in Insider-Led Series C Financing and Appoints Anna Protopapas as Chief Executive Officerglobenewswire.com · Jun 2026

Flare Therapeutics Launches with $82 Million Series A Financing to Advance Precision Oncology Pipeline based on Novel Drug Discovery Approach for Transcription Factors - Flare Therapeutics | Flare Therapeuticsflaretx.com · May 2021

Frequently asked questions

What does Flare Therapeutics do?: Flare Therapeutics develops small molecule medicines targeting transcription factors using a chemistry and proteomics platform that enables ligand discovery directly from cells. The company has lead programs in prostate cancer and advanced urothelial cancer, and maintains a partnership with Roche.
Who founded Flare Therapeutics?: Flare Therapeutics was founded by Jim Audia, Jacob Stuckey.
Who are Flare Therapeutics's investors?: Flare Therapeutics's investors include NexTech Ventures, Pfizer Ventures, Third Rock Ventures, Nextech Invest, Pfizer Venture Investments, ShangBay Capital LLC, Agent Capital.
How much funding has Flare Therapeutics raised?: Flare Therapeutics has disclosed $85M raised across 1 of its 4 known rounds.